1.49
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 1.50 0.01 +0.67%
loading
Precedente Chiudi:
$1.49
Aprire:
$1.48
Volume 24 ore:
172.87K
Relative Volume:
0.43
Capitalizzazione di mercato:
$82.92M
Reddito:
$69.23M
Utile/perdita netta:
$-33.10M
Rapporto P/E:
-1.2627
EPS:
-1.18
Flusso di cassa netto:
$-39.26M
1 W Prestazione:
+0.68%
1M Prestazione:
+29.57%
6M Prestazione:
-16.29%
1 anno Prestazione:
-44.40%
Intervallo 1D:
Value
$1.4461
$1.53
Intervallo di 1 settimana:
Value
$1.40
$1.66
Portata 52W:
Value
$0.52
$5.0699

Neuronetics Inc Stock (STIM) Company Profile

Name
Nome
Neuronetics Inc
Name
Telefono
877-600-7555
Name
Indirizzo
3222 PHOENIXVILLE PIKE, MALVERN, PA
Name
Dipendente
201
Name
Cinguettio
@tmstherapy
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
STIM's Discussions on Twitter

Confronta STIM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
STIM
Neuronetics Inc
1.49 82.92M 69.23M -33.10M -39.26M -1.18
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
532.02 203.50B 42.37B 6.14B 7.78B 15.95
Diagnostics & Research icon
DHR
Danaher Corp
234.84 169.62B 23.74B 3.89B 4.98B 5.24
Diagnostics & Research icon
A
Agilent Technologies Inc
135.69 38.75B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
197.39 35.83B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
415.53 34.03B 3.84B 866.24M 792.60M 10.37

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-13 Downgrade William Blair Outperform → Mkt Perform
2021-10-13 Downgrade BTIG Research Buy → Neutral
2021-10-13 Downgrade William Blair Outperform → Mkt Perform
2021-01-22 Aggiornamento William Blair Mkt Perform → Outperform
2020-02-06 Iniziato BTIG Research Buy
2018-07-24 Iniziato Canaccord Genuity Buy
Mostra tutto

Neuronetics Inc Borsa (STIM) Ultime notizie

pulisher
Jan 03, 2025

Neuronetics Awards Stock Units to New Employee Bill Leonard - MSN

Jan 03, 2025
pulisher
Jan 02, 2025

Neuronetics (NASDAQ:STIM) Is Making Moderate Use Of Debt - Simply Wall St

Jan 02, 2025
pulisher
Dec 26, 2024

HighTower Advisors LLC Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World

Dec 26, 2024
pulisher
Dec 23, 2024

Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com

Dec 23, 2024
pulisher
Dec 20, 2024

Neuronetics Revamps TrakStar System, Streamlining Patient Data Management - MSN

Dec 20, 2024
pulisher
Dec 19, 2024

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 19, 2024
pulisher
Dec 18, 2024

Neuronetics Grants Strategic 50,000 PRSU Inducement Award to Key New Employee - StockTitan

Dec 18, 2024
pulisher
Dec 17, 2024

Neuronetics' SWOT analysis: merger impact on neurohealth stock By Investing.com - Investing.com Australia

Dec 17, 2024
pulisher
Dec 16, 2024

Neuronetics Unveils Strategic Performance-Based Stock Awards Targeting Cash Flow Breakeven by 2025 - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Neuronetics' SWOT analysis: merger impact on neurohealth stock - Investing.com

Dec 16, 2024
pulisher
Dec 11, 2024

Neuronetics, Greenbrook TMS close transaction - Medical Buyer

Dec 11, 2024
pulisher
Dec 10, 2024

Neuronetics Expands with Greenbrook TMS Acquisition - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

Madryn Provides Update on Holdings of Greenbrook TMS Inc. - The Manila Times

Dec 10, 2024
pulisher
Dec 10, 2024

Neuronetics and Greenbrook TMS Announce Closing of Transaction - The Manila Times

Dec 10, 2024
pulisher
Dec 07, 2024

Reviewing Stryker (NYSE:SYK) & Neuronetics (NASDAQ:STIM) - Defense World

Dec 07, 2024
pulisher
Dec 05, 2024

Neuronetics' SWOT analysis: merger, market challenges shape TMS stock outlook - Investing.com Nigeria

Dec 05, 2024
pulisher
Dec 01, 2024

Neuronetics (STU:NRC) 3-Year EPS without NRI Growth Rate : 9.40% (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024
pulisher
Dec 01, 2024

Neuronetics (STU:NRC) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024
pulisher
Nov 29, 2024

Greenbrook TMS Q3 Revenue Up 9% to $18.9M, Plans to Close 23 Centers Amid Merger - StockTitan

Nov 29, 2024
pulisher
Nov 27, 2024

Transcranial Magnetic Stimulator Market Overall Study Report - openPR

Nov 27, 2024
pulisher
Nov 26, 2024

GSA Capital Partners LLP Purchases 30,837 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World

Nov 26, 2024
pulisher
Nov 25, 2024

Transcranial Magnetic Stimulator Market Future Business - openPR

Nov 25, 2024
pulisher
Nov 23, 2024

FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN

Nov 23, 2024
pulisher
Nov 23, 2024

Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN

Nov 23, 2024
pulisher
Nov 21, 2024

Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics - TipRanks

Nov 21, 2024
pulisher
Nov 21, 2024

Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval - MSN

Nov 21, 2024
pulisher
Nov 20, 2024

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Neuronetics to Present at Piper Sandler Healthcare Conference in December 2024 | STIM Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Neuronetics Grants Inducement Awards to New Employees - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12% - Simply Wall St

Nov 18, 2024
pulisher
Nov 18, 2024

Neuronetics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 18, 2024
pulisher
Nov 17, 2024

Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025 - Yahoo Finance

Nov 17, 2024
pulisher
Nov 16, 2024

William Blair Decreases Earnings Estimates for Neuronetics - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Greenbrook TMS Acquisition by Neuronetics Approved - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Neuronetics regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia

Nov 15, 2024
pulisher
Nov 14, 2024

CANNELL CAPITAL LLC Adjusts Stake in Neuronetics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Neuronetics Inc. (STIM) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Earnings call: Neuronetics reports revenue growth amidst strategic shifts By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 13, 2024

Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

Neuronetics regains Nasdaq compliance with bid price - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: Neuronetics reports revenue growth amidst strategic shifts - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Neuronetics, Inc. (NASDAQ:STIM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Neuronetics announces inducement grant - Medical Buyer

Nov 13, 2024

Neuronetics Inc Azioni (STIM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Neuronetics Inc Azioni (STIM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
Oct 08 '24
Sale
0.82
1,541
1,264
402,792
diagnostics_research LH
$229.15
price up icon 0.42%
$136.01
price up icon 3.88%
diagnostics_research WAT
$371.76
price up icon 0.95%
$167.60
price up icon 4.36%
diagnostics_research MTD
$1,238.28
price up icon 1.43%
$415.53
price up icon 1.63%
Capitalizzazione:     |  Volume (24 ore):